Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Nitrosourea-amino sugar conjugate, DNA cross-li...
c-Raf inhibitor, tyrosine kinase inhibitor.
Endogenous peptide hormone, involved in water h...
Microtubule depolymerization inhibitor.
Amide form of vitamin B3 required for productio...
Impurity of rapamycin
Neuropeptide found in Locusta migratoria.
Nucleoside (deoxyadenosine) analog; DNA chain t...
5-HT1A agonist, α1-adrenergic antagonist.
Thienylbutyl ITC analog.
Peptide fragment of HER2/neu/erbB2 receptor.
Endogenous RF-amide peptide, involved in nocice...
Octapeptide derived from activity-dependent neu...
Cannabinoid receptor 2 selective agonist.
ATP-sensitive K+ channel activator, α-adrenerg...
Hydrophobic β-lactam; penicillin binding prote...
Nitrosourea, DNA cross-linker.
Potent and selective inhibitor
Tripeptide, binds cell surface integrins.
Fluoroquinolone; bacterial DNA gyrase inhibitor...